Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Neutral M&G (MNG) by Citi
- Neutral Legal & General Group (LGEN) by Citi
- Neutral SSE (SSE) by Goldman Sachs
- Neutral National Grid (NG.) by Goldman Sachs
- Add Imperial Brands (IMB) by Simon Watkins in The Motley Fool
- Buy Essentra (ESNT) by Tom Winnifrith in ShareProphets
- Sell Wetherspoon (J.D.) (JDW) by Deutsche Bank
- Hold Melrose Industries (MRO) by Deutsche Bank
- Buy DFS Furniture (DFS) by Berenberg
- Add Standard Life plc (SDLF) by Simon Watkins in The Motley Fool
- Hold Lloyds Banking Group (LLOY) by Cliff D'Arcy in The Motley Fool
- Overweight Sabre Insurance Group (SBRE) by Barclays
- Equal Weight Lancashire Holdings Limited (LRE) by Barclays
- Overweight Hiscox Limited (DI) (HSX) by Barclays
- Buy Johnson Matthey (JMAT) by Berenberg
- Buy Croda International (CRDA) by Goldman Sachs
- Underperform Legal & General Group (LGEN) by RBC Capital
- Buy Oxford Biomedica (OXB) by Jefferies
- Buy Balfour Beatty (BBY) by Jefferies
- Sell KEFI Gold and Copper (KEFI) by Nigel Somerville in ShareProphets
Physiomics (PYC) Share Price
Health Care Sector
NOTE: This is based on 19 open tips for Physiomics (PYC)
| Latest Bid : 0.43p | Latest Ask : 0.44p |
| High Today : 0.45p | Low Today : 0.40p |
| This Years High : 0.62p | This Years Low : 0.26p |
| Volume : 5,563,607 | MKT Cap : £0.89M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000
Physiomics (PYC) Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.Physiomics (PYC) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2026-02-16 16:20:00 16/02/2026 | 12.00% |
| Avoid | Steve Moore | Premium Only | 2025-02-13 13:45:00 13/02/2025 | 12.00% |
| Avoid | Steve Moore | Premium Only | 2024-09-27 09:25:00 27/09/2024 | 26.67% |
| Avoid | Steve Moore | Premium Only | 2024-07-03 12:05:00 03/07/2024 | 26.67% |
| Avoid | Steve Moore | Premium Only | 2024-05-03 14:25:00 03/05/2024 | 63.33% |
Physiomics (PYC) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 0.43p | Latest Ask : 0.44p |
| High Today : 0.45p | Low Today : 0.40p |
| This Years High : 0.62p | This Years Low : 0.26p |
| Volume : 5,563,607 | MKT Cap : £0.89M |
Physiomics Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Physiomics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2026-02-16 16:20:00 16/02/2026 | 12.00% |
| Avoid | Steve Moore | Premium Only | 2025-02-13 13:45:00 13/02/2025 | 12.00% |
| Avoid | Steve Moore | Premium Only | 2024-09-27 09:25:00 27/09/2024 | 26.67% |
| Avoid | Steve Moore | Premium Only | 2024-07-03 12:05:00 03/07/2024 | 26.67% |
| Avoid | Steve Moore | Premium Only | 2024-05-03 14:25:00 03/05/2024 | 63.33% |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000